Page last updated: 2024-08-18

isomethyleugenol and ST Elevation Myocardial Infarction

isomethyleugenol has been researched along with ST Elevation Myocardial Infarction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Akhmedov, A; Ambrosini, S; Beltrami, AP; Brown, PJ; Camici, GG; Costantino, S; Crea, F; Gorica, E; Hamdani, N; Herwig, M; Kiss, A; Kolijn, D; Liuzzo, G; Lüscher, TF; Matter, CM; Mohammed, SA; Montecucco, F; Paneni, F; Pedicino, D; Podesser, B; Rossi, FMV; Ruschitzka, F; Russo, G; Sciarretta, S; Szabó, PL; Vinci, R; Weber, L1
Shangguan, Q; Sheng, G; Xie, G; Yang, J; Yang, M1

Other Studies

2 other study(ies) available for isomethyleugenol and ST Elevation Myocardial Infarction

ArticleYear
Methylation of the Hippo effector YAP by the methyltransferase SETD7 drives myocardial ischaemic injury: a translational study.
    Cardiovascular research, 2023, 01-18, Volume: 118, Issue:17

    Topics: Animals; Antioxidants; Apoptosis; Histone-Lysine N-Methyltransferase; Humans; Leukocytes, Mononuclear; Methylation; Mice; Mice, Knockout; Myocytes, Cardiac; Rats; ST Elevation Myocardial Infarction

2023
M6A regulator methylation patterns and characteristics of immunity in acute ST-segment elevation myocardial infarction.
    Scientific reports, 2023, 09-21, Volume: 13, Issue:1

    Topics: Animals; Arrhythmias, Cardiac; Gene Regulatory Networks; Humans; Mammals; Methylation; Nomograms; ST Elevation Myocardial Infarction

2023